<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>31</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Association of p53 codon 72 Arg&gt;Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis 
</title>
	<subject_fa>Meta-analysis</subject_fa>
	<subject>Meta-analysis</subject>
	<content_type_fa></content_type_fa>
	<content_type>Systematic Review</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Different studies have investigated the association between p53 codon 72 Arg&gt;Pro polymorphism and cancer risk. Because of the lack of consensus of the results in individual studies, we conducted this meta-analysis by pooling all currently available case&amp;ndash;control studies to estimate the effect of p53 codon 72 Arg/Pro polymorphism on cancer susceptibility in Iranian population.&lt;br&gt;
&lt;strong&gt;&amp;nbsp;&amp;nbsp; Methods:&lt;/strong&gt; A comprehensive search was undertaken and primary data from all peer-reviewed journals indexed in PubMed, Google Scholar, Scopus, Magiran, Scientific Information Databank (SID), Iran Medex, and CAB abstract electronic were used to conduct this meta-analysis. We considered some exclusion and inclusion criteria to select the articles. Statistical heterogeneity was explored using the I-square. Publication bias was assessed graphically and statistically by Begg&amp;rsquo;s funnel plot and Egger test. All statistical analyses were performed using StatsDirect software and a two- tailed test. P-value less than 0.05 was considered statistically significant for any test.&lt;br&gt;
&lt;strong&gt;&amp;nbsp;&amp;nbsp; Results:&lt;/strong&gt; Our dataset, which included 35 case-control studies, consisted of 2426 cancer cases and 2928 controls. Pooled OR and 95%CI indicated that codon 72 Arg&gt;Pro polymorphism was not associated with odds of developing cancer among Iranian population in the dominant model (Pro/Pro+Arg/Pro vs. Arg/Arg:&amp;nbsp; OR= 0.96, 95%CI= 0.74 to 1.24 chi2= 0.06, p= 0.8). Moreover, no significant association was detected in variant allele (Pro vs Arg: OR= 1.075, 95%CI= 0.91 to 1.25), homozygous (Pro/Pro vs Arg/Arg: OR=0.911 95%CI= 0.66 to 1.25), and heterozygous (Arg/Pro vs Arg/Arg: OR= 0.84, 95%CI= 0.7 to 1).&lt;br&gt;
&lt;strong&gt;&amp;nbsp;&amp;nbsp; Conclusion:&lt;/strong&gt; Our study revealed that p53 codon 72 Arg&gt;Pro polymorphism was not associated with overall cancer odds in Iranian population.&lt;br&gt;
&amp;nbsp;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Meta-analysis, Cancer, p53, Iran

</keyword>
	<start_page>896</start_page>
	<end_page>902</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3066-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Daem</first_name>
	<middle_name></middle_name>
	<last_name>Roshani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>d.roshani@muk.ac.ir</email>
	<code>200319475328460035710</code>
	<orcid>200319475328460035710</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alina</first_name>
	<middle_name></middle_name>
	<last_name> Abdolahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alina.abdolahi@yahoo.com</email>
	<code>200319475328460035711</code>
	<orcid>200319475328460035711</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Cellular and Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shima </first_name>
	<middle_name></middle_name>
	<last_name>Rahmati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rahmati_may66@yahoo.com</email>
	<code>200319475328460035712</code>
	<orcid>200319475328460035712</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Cellular and Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
